Northwestern Mutual Wealth Management
APRE icon

Northwestern Mutual Wealth Management’s Aprea Therapeutics APRE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-47
Closed -$148 – 3276
2023
Q2 		$148 Buy
+47
New +$175 ﹤0.01% 3253

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Northwestern Mutual Wealth Management's APRE Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Aprea Therapeutics (APRE) in Q3 2023, closing a stake of 47 shares — an estimated $148 sold.

Northwestern Mutual Wealth Management first reported a position in APRE in Q2 2023 and held it in 1 quarter. The position peaked at $148 in Q2 2023. 21 funds tracked by Wall St. Rank hold APRE as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Aprea Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 47 Aprea Therapeutics shares in Q3 2023, an estimated $148.
  • Northwestern Mutual Wealth Management first reported a position in Aprea Therapeutics in Q2 2023 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Aprea Therapeutics position peaked at $148 in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.